Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, 127 Changle Western Road, Xi'an, 710032, P.R. China.
J Orthop Res. 2013 Nov;31(11):1804-13. doi: 10.1002/jor.22439. Epub 2013 Aug 2.
Biologic and cellular treatment strategies aiming for curing intervertebral disc degeneration (IDD) have been proposed recently. Given the convenient availability and expansion potential, adipose-derived stromal cells (ADSCs) might be an ideal cell candidate. However, the interaction between ADSCs and nucleus pulposus (NP) cells still remains ambiguous, especially in direct co-cultures of the two types of cells. Nevertheless, NP markers in ADSCs after co-cultures were unidentified. Here, we addressed the interaction of human ADSCs and NP cells in a direct co-culture system for the first time. As a result, ADSCs could differentiate to the NP cell phenotype with a significant up-regulated expression of multiple genes and proteins in extracellular matrix (ECM) (SOX9, COL2A1, ACAN, and COL6A2), relative NP markers (FOXF1, PAX1, CA12, and HBB) and pertinent growth factors (CDMP-1, TGF-β1, IGF-1, and CTGF). Moreover, the gene expression of COL2A1, ACAN, and COL6A2 of degenerate NP cells was also up-regulated. Collectively, these results suggest that direct co-cultures of ADSCs and NP cells may exert a reciprocal impact, that is, both stimulating ADSCs differentiation to the NP cell phenotype and inducing NP cells to regain functional phenotype. Accordingly, ADSCs might be a potential candidate in the development of cellular treatment strategies for IDD.
最近提出了旨在治疗椎间盘退行性变(IDD)的生物和细胞治疗策略。鉴于脂肪来源的基质细胞(ADSCs)方便获得和扩增潜力,ADSCs 可能是一种理想的细胞候选物。然而,ADSCs 与髓核(NP)细胞之间的相互作用仍然不清楚,特别是在两种细胞的直接共培养中。然而,共培养后 ADCSs 中的 NP 标志物仍未确定。在这里,我们首次在直接共培养系统中研究了人 ADSCs 和 NP 细胞之间的相互作用。结果表明,ADSCs 可以分化为 NP 细胞表型,细胞外基质(ECM)中多种基因和蛋白(SOX9、COL2A1、ACAN 和 COL6A2)、相对 NP 标志物(FOXF1、PAX1、CA12 和 HBB)和相关生长因子(CDMP-1、TGF-β1、IGF-1 和 CTGF)的表达显著上调。此外,退变 NP 细胞的 COL2A1、ACAN 和 COL6A2 基因表达也上调。综上所述,这些结果表明 ADCS 和 NP 细胞的直接共培养可能会产生相互影响,即两者都能刺激 ADCS 分化为 NP 细胞表型,并诱导 NP 细胞恢复功能表型。因此,ADSCs 可能是 IDD 细胞治疗策略开发的潜在候选物。